Valuation (84%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 9.79 | N/A |
| PEG Ratio (TTM) | 5.75 | N/A |
| P/S Ratio (TTM) | 0.22 | N/A |
| P/B Ratio (TTM) | 1.12 | N/A |
| P/FCF Ratio (TTM) | 11.54 | N/A |
| Price to 5YR AVG Earnings Ratio | 13.14 | N/A |
| Price to 5YR AVG FCF Ratio | 13.07 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.68% | N/A |
| ROE (TTM) | 11.27% | N/A |
| Net Profit Margin (TTM) | 2.33% | N/A |
| ROIC 5YR AVG | 10.87% | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 5.72% | 9.04% | 18.52% |
| Revenue | -0.79% | -2.43% | 2.70% |
| Net Income | 4.57% | 7.49% | 16.96% |
| Cash Flow | 209.84% | -25.05% | -0.08% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.33 | N/A |
| Quick Ratio (TTM) | 1.03 | N/A |
| D/E Ratio (TTM) | 0.59 | N/A |
| Interest Coverage (TTM) | 7.86 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 2.79 | N/A |
| LTL to 5YR AVG FCF | 6.92 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.34% | N/A |